Table 1.

Demographics.

	All patients (n = 15)	Alive (n = 8)	Died (n = 7)
Median age (IQR)	66.2 (41.6–72.1)	53.1 (34.5–72.8)	66.2 (50.0–73.3)
Sex
Female—no. (%)	4 (27)	2 (25)	2 (29)
Male—no. (%)	11 (73)	6 (75)	5 (71)
Race
White—no. (%)	6 (40)	2 (25)	4 (57)
Black or African American—no. (%)	2 (13)	1 (13)	1 (14)
Other race—no. (%)	7 (47)	5 (62)	2 (29)
Ethnicity
Hispanic—no. (%)	9 (60)	4 (50)	5 (71)
Not Hispanic—no. (%)	6 (40)	4 (50)	2 (29)
Chronic underlying conditions—no. (%)
Hypertension	9 (60)	4 (50)	5 (71)
Cardiovascular disease	2 (13)	0 (0)	2 (29)
Congestive heart failure	2 (13)	1 (13)	1 (14)
Diabetes	1 (7)	0 (0)	1 (14)
COPD	1 (7)	0 (0)	1 (14)
Renal failure	1 (7)	0 (0)	1 (14)
Malignancy	1 (7)	1 (13)	0 (0)
Liver disease	0 (0)	0 (0)	0 (0)
Median BMI (IQR)	29. 6 (27.3–31.9)	27.7 (24.8–31.9)	30.3 (29.5–35)
At the time of sample
ARDS—no. (%)	6 (40)	3 (38)	3 (43)
Vassopressor support—no. (%)	2 (13)	1 (13)	1 (14)
Median SOFA score (IQR)	6 (3–8)	7.5 (4–8)	3 (2–6)
Median APACHE II score (IQR)	18 (13.5–23)	20.5 (17.3–24.5)	12 (9–22)
Ordinal scale 4—no. (%)	3 (20)	3 (38)	0(0)
Ordinal scale 5—no. (%)	8 (53)	1 (13)	7 (100)
Ordinal scale 6—no. (%)	1 (7)	1 (13)	0 (0)
Ordinal scale 7—no. (%)	3 (20)	3 (38)	0 (0)
Hospital course
Median ventilator days (IQR)	6 (0–30)	7.5 (0–45.75)	2 (0–27)
Median ICU length of stay (IQR)	15 (6.5–35.5)	9 (3.5–36.25)	18 (8–44)
Median hospital length of stay (IQR)	22 (13–49.5)	25 (8.75–71.25)	22 (15–45)
ECMO—no. (%)	3 (20)	2 (25)	1 (14)
Acute renal replacement—no. (%)	4 (27)	2 (25)	2 (29)
Thrombotic event—no. (%)	6 (40)	3 (38)	3 (43)
Death—no. (%)	7 (47)
Discharge from hospital—no. (%)	8 (53)
Median D dimer (IQR)	2980 (974–4312)	2657 (885–4433)	3370 (923–7180)
TEG hypercoagulable—no. (%)	6 (40)	3 (38)	3 (43)
Remdesivir—no. (%)	8 (53)	4 (50)	4 (57)
Plasma—no. (%)	2 (13)	1 (13)	1 (14)